HC Wainwright & Co.：上調RAPT Therapeutics評級

證券之星

2024-12-26

HC Wainwright&Co.：上調rapt therapeutics(RAPT.US)評級，由中性調整至買入評級,目標價由10.00美元調整至10.00美元。RAPT Therapeutics(RAPT.US)公司簡介：RAPT Therapeutics Inc是一家基於臨牀階段的免疫學生物製藥公司。它專注於發現、開發和商業化口服小分子療法用於未滿足需求的腫瘤和炎症疾病患者。該公司的管道產品...

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2494516388"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2494516388\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2494516388?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2024-12-26 19:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2494516388","market":"us","top_or_hot":-1,"title":"HC Wainwright & Co.：上調RAPT Therapeutics評級","media":"證券之星","content":"<div>\n<p>HC Wainwright&Co.：上調rapt therapeutics(RAPT.US)評級，由中性調整至買入評級,目標價由10.00美元調整至10.00美元。RAPT Therapeutics(RAPT.US)公司簡介：RAPT Therapeutics Inc是一家基於臨牀階段的免疫學生物製藥公司。它專注於發現、開發和商業化口服小分子療法用於未滿足需求的腫瘤和炎症疾病患者。該公司的管道產品...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226194513ab935e8a&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HC Wainwright & Co.：上調RAPT Therapeutics評級</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHC Wainwright & Co.：上調RAPT Therapeutics評級\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">證券之星</strong><span class=\"h-time small\">2024-12-26 19:34</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>HC Wainwright&Co.：上調rapt therapeutics(RAPT.US)評級，由中性調整至買入評級,目標價由10.00美元調整至10.00美元。RAPT Therapeutics(RAPT.US)公司簡介：RAPT Therapeutics Inc是一家基於臨牀階段的免疫學生物製藥公司。它專注於發現、開發和商業化口服小分子療法用於未滿足需求的腫瘤和炎症疾病患者。該公司的管道產品...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226194513ab935e8a&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226194513ab935e8a&s=b\">證券之星</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226194513ab935e8a&s=b","article_id":"2494516388","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226194513ab935e8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2494516388","pubTimestamp":1735212893,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"HC Wainwright&Co.：上調rapt therapeutics(RAPT.US)評級，由中性調整至買入評級,目標價由10.00美元調整至10.00美元。RAPT Therapeutics(RAPT.US)公司簡介：RAPT Therapeutics Inc是一家基於臨牀階段的免疫學生物製藥公司。它專注於發現、開發和商業化口服小分子療法用於未滿足需求的腫瘤和炎症疾病患者。該公司的管道產品包括FLX475，旨在選擇性地抑制免疫抑制調節性T細胞向腫瘤的遷移;RPT193，旨在選擇性地抑制2型T輔助細胞向炎症組織的遷移。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","RAPT":"RAPT Therapeutics, Inc."},"translate_title":"HC Wainwright & Co.: RAPT Therapeutics Rating Upgraded","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"RAPT":1},"content_text":"HC Wainwright&Co.：上調rapt therapeutics(RAPT.US)評級，由中性調整至買入評級,目標價由10.00美元調整至10.00美元。RAPT Therapeutics(RAPT.US)公司簡介：RAPT Therapeutics Inc是一家基於臨牀階段的免疫學生物製藥公司。它專注於發現、開發和商業化口服小分子療法用於未滿足需求的腫瘤和炎症疾病患者。該公司的管道產品包括FLX475，旨在選擇性地抑制免疫抑制調節性T細胞向腫瘤的遷移;RPT193，旨在選擇性地抑制2型T輔助細胞向炎症組織的遷移。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}